INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
ORDER A TEST Log In Contact Us
Back TO events
October 9 — 10, 2024 BASEL, SWITZERLAND

Exhibit Booth #730
Conference Session

BioTechX Europe 2024

From research & discovery to clinical care, Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to share our latest AI-enabled technologies during the 2024 BioTechX Europe conference.

Schedule a meeting with us
Conference Session
October 9, 2024
live session
Time
14:50–15:10

Location
Messe Basel
Basel, Switzerland
Presenter
Ryan Fukushima
Chief Operating Officer (Tempus)

Oncology Innovation: How Emerging Biotechs Lead Through RWD & AI

A part of the ‘Real World Evidence’ track

In an evolving biotech landscape, emerging companies are harnessing the power of real-world data (RWD) and artificial intelligence (AI) to help accelerate oncology drug development. This presentation explores how these cutting-edge tools help biotechs streamline clinical trials, optimize patient selection, and improve decision-making, even amidst challenging market conditions. Join us to discover how biotechs are leading the next wave of oncology innovation by leveraging advanced data strategies to bring therapies to patients faster and more effectively.

Schedule a meeting with us

We'll be in touch shortly.